Expanded Access Program (EAP) for Obecabtagene Autoleucel (obe-cel) Out-of-specification (OOS) in Adult Patients with Acute Lymphoblastic Leukemia
- Sponsor:
- Autolus, Inc
- Sponsor Study ID:
- AUTO1-OS1
- CTO #:
- 104194
- NCT Number:
- NCT06799221
- Phase:
- N/A
- Protocol Type:
- Treatment
- Age Group:
- Adults
- Disease Sites:
- Myeloid and Monocytic Leukemia
- Study Objectives:
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Baratam, Praneeth, at baratamp@musc.edu
- Study Coordinator, Baker, Hana, at bakerhan@musc.edu
Trial opened at the following institutions:
Medical University of South Carolina